Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish

被引:251
|
作者
Cheshenko, Ksenia [1 ]
Pakdel, Farzad [2 ]
Segner, Helmut [3 ]
Kah, Olivier [2 ]
Eggen, Rik I. L. [1 ]
机构
[1] Swiss Fed Inst Aquat Sci & Technol, CH-8600 Dubendorf, Switzerland
[2] Univ Rennes 1, CNRS, UMR 6026, F-35042 Rennes, France
[3] Univ Bern, Ctr Fish & Wildlife Hlth, CH-3001 Bern, Switzerland
关键词
endocrine disrupters; aromatase; cyp19a; cyp19b; brain; gonad; estrogens; xenoestrogens; dioxin; reproduction; fish; teleost;
D O I
10.1016/j.ygcen.2007.03.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many natural and synthetic compounds present in the environment exert a number of adverse effects on the exposed organisms, leading to endocrine disruption, for which they were termed endocrine disrupting chemicals (EDCs). A decrease in reproduction success is one of the most well-documented signs of endocrine disruption in fish. Estrogens are steroid hormones involved in the control of important reproduction-related processes, including sexual differentiation, maturation and a variety of others. Careful spatial and temporal balance of estrogens in the body is crucial for proper functioning. At the final step of estrogen biosynthesis, cytochrome P450 aromatase, encoded by the cyp19 gene, converts androgens into estrogens. Modulation of aromatase CYP19 expression and function can dramatically alter the rate of estrogen production, disturbing the local and systemic levels of estrogens. In the present review, the current progress in CYP19 characterization in teleost fish is summarized and the potential of several classes of EDCs to interfere with CYP19 expression and activity is discussed. Two cyp19 genes are present in most teleosts, cyp19a and cyp19b, primarily expressed in the ovary and brain, respectively. Both aromatase CYP19 isoforms are involved in the sexual differentiation and regulation of the reproductive cycle and male reproductive behavior in diverse teleost species. Alteration of aromatase CYP19 expression and/or activity, be it upregulation or downregulation, may lead to diverse disturbances of the above mentioned processes. Prediction of multiple transcriptional regulatory elements in the promoters of teleost cyp19 genes suggests the possibility for several EDC classes to affect cyp19 expression on the transcriptional level. These sites include cAMP responsive elements, a steroidogenic factor 1/adrenal 4 binding protein site, an estrogen-responsive element (ERE), half-EREs, dioxin-responsive elements, and elements related to diverse other nuclear receptors (peroxisome proliferator activated receptor, retinoid X receptor, retinoic acid receptor). Certain compounds including phytoestrogens, xenoestrogens, fungicides and organotins may modulate aromatase CYP19 activity on the post-transcriptional level. As is shown in this review, diverse EDCs may affect the expression and/or activity of aromatase cyp19 genes through a variety of mechanisms, many of which need further characterization in order to improve the prediction of risks posed by a contaminated environment to teleost fish population. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:31 / 62
页数:32
相关论文
共 42 条
  • [1] Modulation of aromatase activity as a mode of action for endocrine disrupting chemicals in a marine fish
    Mills, Lesley J.
    Gutjahr-Gobell, Ruth E.
    Zaroogian, Gerald E.
    Horowitz, Doranne Borsay
    Laws, Susan C.
    AQUATIC TOXICOLOGY, 2014, 147 : 140 - 150
  • [2] Refinement of an OECD test guideline for evaluating the effects of endocrine disrupting chemicals on aromatase gene expression and reproduction using novel transgenic cyp19a1a-eGFP zebrafish
    De Oliveira, Julie
    Chadili, Edith
    Piccini, Benjamin
    Turies, Cyril
    Maillot-Marechal, Emmanuelle
    Palluel, Olivier
    Pardon, Patrick
    Budzinski, Helene
    Cousin, Xavier
    Brion, Francois
    Hinfray, Nathalie
    AQUATIC TOXICOLOGY, 2020, 220
  • [3] Promoter characteristics of two cyp19 genes differentially expressed in the brain and ovary of teleost fish
    Tchoudakova, A
    Kishida, M
    Wood, E
    Callard, GV
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 78 (05) : 427 - 439
  • [4] Phylogeny, expression and enzyme activity of zebrafish cyp19 (P450 aromatase) genes
    Tong, SK
    Chiang, EFL
    Hsiao, PH
    Chung, BC
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) : 299 - 303
  • [5] Expression of aromatase CYP19 and its relationship with parameters in NSCLC
    Oyama, Tsunehiro
    Kagawa, Norio
    Sugio, Kenji
    Uramoto, Hidetaka
    Hatano, Osamu
    Harada, Nobuhiro
    Kaneko, Kazuhiro
    Kawamoto, Toshihiro
    Yasumoto, Kosei
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 2285 - U41
  • [6] CYP19 gene expression and aromatase activity in endometrial cancer tissue: importance of the type of the disease
    Berstein, L
    Zimarina, T
    Kovalevskij, A
    Maximov, S
    Volkov, O
    Thijssen, JHH
    NEOPLASMA, 2005, 52 (02) : 115 - 118
  • [7] Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro
    Vinggaard, AM
    Hnida, C
    Breinholt, V
    Larsen, JC
    TOXICOLOGY IN VITRO, 2000, 14 (03) : 227 - 234
  • [8] Differential tissue distribution, developmental programming, estrogen regulation and promoter characteristics of cyp19 genes in teleost fish
    Callard, GV
    Tchoudakova, AV
    Kishida, M
    Wood, E
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 79 (1-5) : 305 - 314
  • [9] Endocrine disrupting chemicals and sexual behaviors in fish - a critical review on effects and possible consequences
    Soeffker, Marta
    Tyler, Charles R.
    CRITICAL REVIEWS IN TOXICOLOGY, 2012, 42 (08) : 653 - 668
  • [10] CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity
    Berstein, LM
    Imyanitov, EN
    Kovalevskij, AJ
    Maximov, SJ
    Vasilyev, DA
    Buslov, KG
    Sokolenko, AP
    Iyevleva, AG
    Chekmariova, EV
    Thijssen, JHH
    CANCER LETTERS, 2004, 207 (02) : 191 - 196